About the Study

Research study for e-cigarette smokers that want to quit:
For many people, vaping is supposed to be a way to step down from smoking and eventually quit entirely.  While a better alternative to traditional cigarettes, they are not without risk. They can increase heart rate and blood pressure, increase the risk of bronchitis and lung disease, and increase insulin resistance, which may lead to type 2 diabetes.  There is also no regulation of what goes into vaping oil, so you never really know what you’re getting. Studies have found chemicals such as formaldehyde and antifreeze in vaping oil. And some of the byproducts of vaping have been found to be carcinogenic.

Although vaping is often touted as a way to quit smoking, and is certainly a better alternative, taking that last step down from vaping may be harder than you think. Some studies have found that delivering nicotine in the form of concentrated vapor makes it more potent and therefore more addictive than getting nicotine through smoking cigarettes. Many people claim quitting vaping is even harder than quitting cigarettes.

If you or someone you know really wants to quit vaping but needs help – consider signing up for a clinical research study designed to help people kick the habit for good. The study is about 12 weeks long and is assessing the efficacy of a phase 2 drug in helping adults to quit vaping. 

Compensation may be up to $1,675 for time and travel to participate in the study. Study-related care is available to participants at no cost and health insurance is not required nor needed. If you are interested in joining the study at RCR, call 585-288-0890 or fill in your information. 

Qualifications

  • Daily e-cigarette or vaping usage
  • Motivated to quit e-cigarettes or vaping
  • Are 18 years +
  • Please note, other conditions may apply.